Company Profiles

driven by the PitchBook Platform

BliNK Biomedical

BliNK Biomedical
2015 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series A LATEST DEAL TYPE
$6.25M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of novel antibiotic and research services for monoclonal antibodies. The company focuses on the discovery and development of novel therapeutic antibodies in oncology and immuno-oncology.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
Gerland Plaza Techsud
70, rue Saint-Jean-de-Dieu
69007 Lyon
France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BliNK Biomedical’s full profile, request a free trial.

BliNK Biomedical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 12-Jul-2016 $6.25M 00.000 Completed Product Development
1. Early Stage VC 20-Jan-2015 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

BliNK Biomedical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cancer Research Technology Venture Capital Minority 000 0000 000000 0
IdInvest Partners PE/Buyout Minority 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
Valneva Corporation Minority 000 0000 000000 0

BliNK Biomedical Executive Team (2)

Name Title Board
Seat
Contact
Info
Jack Elands Ph.D Chief Executive Officer & Board Member
Nicola Beltraminelli Ph.D Chief Scientific Officer

BliNK Biomedical Board Members (7)

Name Representing Role Since Contact
Info
Franck Grimaud Valneva Board Member 000 0000
Frederic Legros BliNK Biomedical Board Member 000 0000
Irina Staatz Self Chairman 000 0000
Jack Elands Ph.D BliNK Biomedical Chief Executive Officer & Board Member 000 0000
Michael Owen Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com